A KCC2 cotransporter activator
Related Products
Pro-drug Form(s)
31448CLP 290
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

CLP 257

Item No. 30948

Technical Information
Formal Name
(5Z)-5-[(4-fluoro-2-hydroxyphenyl)methylene]-2-(tetrahydro-1(2H)-pyridazinyl)-4(5H)-thiazolone
CAS Number
1181081-71-9
Molecular Formula
C14H14FN3O2S
Formula Weight
Purity
≥98%
A solid
DMSO: 20 mg/ml
SMILES
FC1=CC=C(/C=C2SC(N3NCCCC3)=NC\2=O)C(O)=C1
InChi Code
InChI=1S/C14H14FN3O2S/c15-10-4-3-9(11(19)8-10)7-12-13(20)17-14(21-12)18-6-2-1-5-16-18/h3-4,7-8,16,19H,1-2,5-6H2/b12-7-
InChi Key
SKCADXVKQRCWTR-GHXNOFRVSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    CLP 257 is a K+/Cl- cotransporter 2 (KCC2) activator.1,2,3 It induces chloride transport in NG108-cl cells that endogenously express low levels of KCC2 (EC50 = 616 nM).1 It is selective for KCC2 over GABAA receptors at 50 µM. CLP 257 (25 µM) increases the rate of chloride accumulation in spinal slices isolated from a rat model of peripheral nerve injury and BDNF control slices, which exhibit reduced levels of KCC2. In vivo, CLP 257 (100 mg/kg) increases mechanical and withdrawal thresholds in a rat model of peripheral nerve injury and reverses morphine-induced hyperalgesia in rats.1,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Gagnon, M., Bergeron, M.J., Lavertu, G., et al. Chloride extrusion enhancers as novel therapeutics for neurological diseases. Nat. Med. 19(11), 1524-1528 (2013).

    2. Cardarelli, R.A., Jones, K., Pisella, L.I., et al. The small molecule CLP257 does not modify activity of the K+-Cl- co-tansporter KCC2 but does potentiate GABAA receptor activity. Nat. Med. 23(12), 1394-1396 (2017).

    3. Gagnon, M., Bergeron, M.J., Perez-Sanchez, J., et al. Reply to The small molecule CLP257 does not modify activity of the K+-Cl- co-transporter KCC2 but does potentiate GABAA receptor activity. Nat. Med. 23(12), 1396-1398 (2017).

    4. Ferrini, F., Lorenzo, L.-E., Godin, A.G., et al. Enhancing KCC2 function counteracts morphine-induced hyperalgesia. Sci. Rep. 7(1), 3870 (2017).